260 related articles for article (PubMed ID: 11606823)
1. HLA class II antibodies in transfusion-related acute lung injury.
Kopko PM; Popovsky MA; MacKenzie MR; Paglieroni TG; Muto KN; Holland PV
Transfusion; 2001 Oct; 41(10):1244-8. PubMed ID: 11606823
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
[TBL] [Abstract][Full Text] [Related]
3. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs.
Kopko PM; Paglieroni TG; Popovsky MA; Muto KN; MacKenzie MR; Holland PV
Transfusion; 2003 Feb; 43(2):177-84. PubMed ID: 12559013
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
5. Investigations into the role of anti-HLA class II antibodies in TRALI.
Kao GS; Wood IG; Dorfman DM; Milford EL; Benjamin RJ
Transfusion; 2003 Feb; 43(2):185-91. PubMed ID: 12559014
[TBL] [Abstract][Full Text] [Related]
6. Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome.
Win N; Massey E; Lucas G; Sage D; Brown C; Green A; Contreras M; Navarrete C
Hematology; 2007 Oct; 12(5):461-9. PubMed ID: 17852461
[TBL] [Abstract][Full Text] [Related]
7. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
[TBL] [Abstract][Full Text] [Related]
8. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
Nakagawa M; Toy P
Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies.
Sachs UJ; Wasel W; Bayat B; Bohle RM; Hattar K; Berghöfer H; Reil A; Bux J; Bein G; Santoso S; Weissmann N
Blood; 2011 Jan; 117(2):669-77. PubMed ID: 21030555
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
Popovsky MA; Moore SB
Transfusion; 1985; 25(6):573-7. PubMed ID: 4071603
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
Nicolle AL; Chapman CE; Carter V; Wallis JP
Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
[TBL] [Abstract][Full Text] [Related]
12. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
13. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary injury from transfusion-related acute lung injury.
Kopko PM; Popovsky MA
Clin Chest Med; 2004 Mar; 25(1):105-11. PubMed ID: 15062602
[TBL] [Abstract][Full Text] [Related]
15. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
[TBL] [Abstract][Full Text] [Related]
16. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study.
Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR
Transfusion; 1997 Jul; 37(7):719-26. PubMed ID: 9225936
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-related acute lung injury.
Fabron A; Lopes LB; Bordin JO
J Bras Pneumol; 2007; 33(2):206-12. PubMed ID: 17724541
[TBL] [Abstract][Full Text] [Related]
18. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
[TBL] [Abstract][Full Text] [Related]
19. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
Fontaine MJ; Malone J; Mullins FM; Grumet FC
Ann Clin Lab Sci; 2006; 36(1):53-8. PubMed ID: 16501237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
